Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2006 Jul 27;20(4):164–172. doi: 10.1002/jcla.20126

A serological follow‐up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme‐linked immunosorbent assay

Guita Rubinsky Elefant 1,✉, Sumie Hoshino Shimizu 2, Maria Carmen Arroyo Sanchez 1, Cristina Miuki Abe Jacob 3, Antonio Walter Ferreira 4
PMCID: PMC6807646  PMID: 16874812

Abstract

A serological follow‐up study was carried out on 27 children (1–12 years old) with visceral and/or ocular toxocariasis, after treatment with thiabendazole. A total of 159 serum samples were collected in a period ranging from 22–116 months. Enzyme‐linked immunosorbent assays (IgG, IgA, and IgE ELISA) were standardized, using excretory–secretory antigens obtained from the second‐stage larvae of a Toxocara canis culture. The sensitivity found for the IgG, IgA, and IgE ELISA, as determined in visceral toxocariasis patients, was 100%, 47.8%, and 78.3%, respectively. Approximately 84% of the patients presented single or multiple parasitosis, as diagnosed by stool examination, yet such variables did not appear to affect the anti‐Toxocara immune response. Titers of specific IgE antibody showed a significant decrease during the first year after treatment, followed by a decrease in the IgA titers in the second year, and in the IgG titers from the fourth year onwards. Sera from all patients presented high avidity IgG antibodies, indicating that they were in the chronic phase of the disease. Moreover, 1 year after treatment, the level of leukocytes, eosinophils, and anti‐A isohemagglutinin in patients decreased significantly. The present data suggest that IgE antibodies plus eosinophil counts are helpful parameters for patient follow‐up after chemotherapy. J. Clin. Lab. Anal. 20:164–172, 2006. © 2006 Wiley‐Liss, Inc.

Keywords: toxocariasis, serodiagnosis, immunoenzymatic assay, immunoglobulin isotypes, chemotherapy

REFERENCES

  • 1. Glickman LT, Schantz PM. Epidemiology and pathogenesis of zoonotic Toxocariasis. Epidemiol Rev 1981;3:230–250. [DOI] [PubMed] [Google Scholar]
  • 2. Schantz P. Toxocara larva migrans now. Am J Trop Med Hyg 1989;41:21–34. [DOI] [PubMed] [Google Scholar]
  • 3. Del Prete GF, De Carli M, Mastromauro C, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory‐secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346–350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol 2001;75:299–305. [DOI] [PubMed] [Google Scholar]
  • 5. Jacob CMA, Pastorino AC, Peres BA, Mello EO, Okay Y, Oselka GW. Clinical and laboratorial features of visceral toxocariasis in infancy. Rev Inst Med Trop Sao Paulo 1994;36:19–26. [DOI] [PubMed] [Google Scholar]
  • 6. Taylor MRH. The epidemiology of ocular toxocariasis. J Helminthol 2001;75:109–118. [PubMed] [Google Scholar]
  • 7. Taylor MRH, Keane CT, O'Connor P, Girdwood RWA, Smith H. Clinical features of covert toxocariasis. Scand J Infect Dis 1987;19:693–696. [DOI] [PubMed] [Google Scholar]
  • 8. De Savigny DH. In vitro maintenance of Toxocara canis larvae and a simple method for the production of Toxocara ES antigens for use in serodiagnostic tests for visceral larva migrans. J Parasitol 1975:61:781–782. [PubMed] [Google Scholar]
  • 9. Magnaval JF, Fabre R, Maurières P, Charlet JP, De Larrard B. Application of the Western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res 1991;77:697–702. [DOI] [PubMed] [Google Scholar]
  • 10. Alderete JMS, Jacob CMA, Pastorino AC, et al. 2003. Prevalence of Toxocara infection in schoolchildren from the Butantã Region, São Paulo, Brazil. Mem Inst Oswaldo Cruz 2003;98:593–597. [DOI] [PubMed] [Google Scholar]
  • 11. De Savigny DH, Voller A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol 1979;32:284–288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Campos JRD, Rubinsky‐Elefant G, Melo E, et al. Frequency of seropositivity to Toxocara canis in children of different socioeconomic strata. Rev Soc Bras Med Trop 2003;36:509–513. [PubMed] [Google Scholar]
  • 13. Hubner J, Uhlikova M, Leissova M. Diagnosis of the early phase of larval toxocariasis using IgG avidity. Epidemiol Mikrobiol Imunol 2001;50:67–70. [PubMed] [Google Scholar]
  • 14. Smith HV. 1993. Antibody reactivity in human Toxocariasis In: Lewis JW, Maizels RM, editors. Toxocara and toxocariasis. Clinical, epidemiological and molecular perspectives. London: British Society for Parasitology Inc; p 91–109. [Google Scholar]
  • 15. Magnaval JF, Fabre R, Maurières P, Charlet JP, De Larrard B. Evaluation of an Immunoenzymatic assay detecting specific anti‐Toxocara immunoglobulin E for diagnosis and post‐treatment follow‐up of human toxocariasis. J Clin Microbiol 1992;30:2269–2274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Obwaller A, Jensen‐Jarolim A, Auer H, Huber A, Kraft D, Aspöck H. Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti‐IgE immune complexes. Parasite Immunol 1998;20:311–317. [DOI] [PubMed] [Google Scholar]
  • 17. Rubinsky‐Elefant G, Jacob CMA, Kanashiro EH, Peres BA. 2001. Toxocaríase In: Ferreira AW, Ávila SLM, editors. Diagnóstico Laboratorial das principais doenças infecciosas e auto‐imunes. São Paulo: Guanabara Koogan Inc; p 323–332. [Google Scholar]
  • 18. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275. [PubMed] [Google Scholar]
  • 19. Nielsen JB. The basis for colored silver‐protein complex formation in stained SDS‐PAGE. Anal Biochem 1984;141:311–315. [DOI] [PubMed] [Google Scholar]
  • 20. Kanamura HY, Hoshino‐Shimizu S, Silva LC. Solubilization of antigen S. mansoni adult worms for the passive hemagglutination test. Rev Inst Med Trop Sao Paulo 1981;23:92–95. [PubMed] [Google Scholar]
  • 21. Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159:736–740. [DOI] [PubMed] [Google Scholar]
  • 22. Hedman K, Rousseau, SA . Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 1989;27:288–292. [DOI] [PubMed] [Google Scholar]
  • 23. Gomes JF, Hoshino‐Shimizu S, Dias LCS, Araujo AJUS, Castilho VLP, Neves FAMA. Evaluation of a novel kit (TF‐Test) for the diagnosis of intestinal parasitic infections. J Clin Lab Anal 2004;18:132–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Holland CV, O'Lorcain P, Taylor MRH, Kelly A. Sero‐epidemiology of toxocariasis in school children. Parasitology 1995;110:535–545. [DOI] [PubMed] [Google Scholar]
  • 25. Maizels RM, De Savigny D, Ogilvie BM. Characterization of surface and excretory‐secretory antigens of Toxocara canis infective larvae. Parasite Immunol 1984;6:23–37. [DOI] [PubMed] [Google Scholar]
  • 26. Badley JE, Grieve RB, Bowman DD, Glickman LT, Rockey JH. Analysis of Toxocara canis larval excretory‐secretory antigens: physicochemical characterization and antibody recognition. J Parasitol 1987;73:593–600. [PubMed] [Google Scholar]
  • 27. Robertson BD, Bianco AT, McKerrow JH, Maizels RM. Proteolytic enzymes secreted by larvae of the nematode Toxocara canis . Exp Parasitol 1989;69:30–36. [DOI] [PubMed] [Google Scholar]
  • 28. Gillespie SH, Bidwell D, Voller A, Robertson BD, Maizels RM. Diagnosis of human toxocariasis by antigen capture enzyme linked immunosorbent assay. J Clin Pathol 1993;46:551–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Dubinsky P, Akao N, Reiterová K, Konáková G. Comparison of the sensitive screening kit with two ELISA sets for detection of anti‐Toxocara antibodies. Southeast Asian J Trop Med Public Health 2000;31:394–398. [PubMed] [Google Scholar]
  • 30. Speiser F, Gottstein B. A collaborative study on larval excretory/secretory antigens of Toxocara canis for the immunodiagnosis of human toxocariasis with ELISA. Acta Trop 1984;41:361–372. [PubMed] [Google Scholar]
  • 31. Aguila C, Cuéllar C, Fenoy S, Guillén JL. Comparative study of assays detecting circulating immune complexes and specific antibodies in patients infected with Toxocara canis . J Helminthol 1987;61:196–202. [DOI] [PubMed] [Google Scholar]
  • 32. Tonz M, Speiser F, Tonz O. Toxocariasis in Swiss children. Schweiz Med Wochenschr 1983;113:1500–1507. [PubMed] [Google Scholar]
  • 33. Luzna‐Lyskov A, Andrzejewska I, Lesicka U, Szewczyk‐Kramska B, Luty T, Pawlowski ZS. Clinical interpretation of eosinophilia and ELISA values (OD) in toxocarosis. Acta Parasitol 2000;45:35–39. [Google Scholar]
  • 34. Taylor MRH. 1993. Toxocariasis in Ireland In: Lewis JW, Maizels RM. Toxocara and Toxocariasis. Clinical, epidemiological and molecular perspectives. London: British Society for Parasitology Inc; p 71–80. [Google Scholar]
  • 35. Cypess RH, Karal MH, Zedian JL, Glickaman LT, Gitlin D. Larva‐specific antibodies in patients with visceral larva migrans. J Infect Dis 1977;135:633–640. [DOI] [PubMed] [Google Scholar]
  • 36. Altcheh J, Nallar M, Conca M, Biancardi M, Freilij H. Toxocariasis: aspectos clínicos y de laboratorio in 54 patients. [Toxocariasis: clinical and laboratory features in 54 patients]. An Pediatr (Barc) 2003;58:425–431. [DOI] [PubMed] [Google Scholar]
  • 37. Smith HV, Kennedy MW. Significance and quantification of antigen‐specific IgE in helminthic infections of humans. J Clin Immunoassay 1993;16:131–143. [Google Scholar]
  • 38. Hedman K, Lappalainem M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123–129. [Google Scholar]
  • 39. Matsumura K, Kazuta Y, Endo R, Tanaka K. The IgA antibody activities in relation to the parasitologic status of Toxocara canis in dogs. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983;256:239–243. [PubMed] [Google Scholar]
  • 40. Julian E, Matas L, Perez A, Alcaide J, Laneelle MA, Luquin M. Serodiagnosis of tuberculosis: comparison of immunoglobulin A (IgA) response to sulfolipid I with IgG and IgM responses to 2,3‐diacyltrehalose, 2,3,6‐triacyltrehalose, and cord factor antigens. J Clin Microbiol 2002;40:3782–3788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Genchi C, Falagiani P, Riva G, et al. IgE and IgG antibodies in Toxocara canis infection. A clinical evaluation. Ann Allergy 1988;61:43–46. [PubMed] [Google Scholar]
  • 42. Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol 2001;39:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Glickman LT, Cypess RH, Crumrine PK, Gitlin DA. Toxocara infection and epilepsy in children. J Pediatr 1979;94:75–78. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES